Return On Equity in % of Klotho Neurosciences, Inc. from 2022 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Klotho Neurosciences, Inc. quarterly/annual Return On Equity history and growth rate from 2022 to Q3 2025.
  • Klotho Neurosciences, Inc. Return On Equity for the quarter ending September 30, 2025 was -202 %, a 89.9% increase year-over-year.
  • Klotho Neurosciences, Inc. annual Return On Equity for 2024 was -1.69K %, a 5870% decline from 2023.
  • Klotho Neurosciences, Inc. annual Return On Equity for 2023 was 29.3 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)

Klotho Neurosciences, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -202 +1.8K +89.9% Jul 1, 2025 Sep 30, 2025
Q2 2025 -326 +6.77K +95.4% Apr 1, 2025 Jun 30, 2025
Q1 2025 -1.78K -1.89K -1728% Jan 1, 2025 Mar 31, 2025
Q4 2024 -1.69K -1.67K -6870% Oct 1, 2024 Dec 31, 2024
Q3 2024 -2K -1.96K -4901% Jul 1, 2024 Sep 30, 2024
Q2 2024 -7.09K -7.04K -14505% Apr 1, 2024 Jun 30, 2024
Q1 2024 109 +164 Jan 1, 2024 Mar 31, 2024
Q4 2023 -24.3 +15.8 +39.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 -40 Jul 1, 2023 Sep 30, 2023
Q2 2023 -48.6 Apr 1, 2023 Jun 30, 2023
Q1 2023 -54.8 Jan 1, 2023 Mar 31, 2023
Q4 2022 -40.1 Oct 1, 2022 Dec 31, 2022

Klotho Neurosciences, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -1.69K -1.72K -5870% Jan 1, 2024 Dec 31, 2024
2023 29.3 +69.4 Jan 1, 2023 Dec 31, 2023
2022 -40.1 Jan 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.